Literature DB >> 11056412

The use of nebulized glutathione in the treatment of emphysema: a case report.

D W Lamson1, M S Brignall.   

Abstract

We present the case of a 95-year-old man with an acute respiratory crisis secondary to emphysema and apparent bronchial infection. Treatment with nebulized glutathione led to a rapid resolution of the crisis, as well as a marked improvement in the chronic course of the disease. This treatment has been used since for a number of patients with emphysema. The safety and bioavailability of this method of delivery have been established in human studies. Preliminary results suggest efficacy for nebulized administration of glutathione in this patient population. We suggest this treatment can be considered an option for acute respiratory crises due to COPD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11056412

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  5 in total

1.  Getting a Knack for NAC: N-Acetyl-Cysteine.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2011-01

2.  Connecting glutathione with immune responses to occupational methylene diphenyl diisocyanate exposure.

Authors:  Adam V Wisnewski; Jian Liu; Carrie A Redlich
Journal:  Chem Biol Interact       Date:  2013-06-20       Impact factor: 5.192

Review 3.  A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins.

Authors:  Janette Hope
Journal:  ScientificWorldJournal       Date:  2013-04-18

4.  The treatment of pulmonary diseases and respiratory-related conditions with inhaled (nebulized or aerosolized) glutathione.

Authors:  Jonathan Prousky
Journal:  Evid Based Complement Alternat Med       Date:  2008-03       Impact factor: 2.629

Review 5.  Targeting Aging Pathways in Chronic Obstructive Pulmonary Disease.

Authors:  Molly Easter; Seth Bollenbecker; Jarrod W Barnes; Stefanie Krick
Journal:  Int J Mol Sci       Date:  2020-09-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.